Silverman, who joined the College of Information Sciences and Technology last year as an assistant professor with a focus in biomedical statistics, made global headlines last summer for his study suggesting that 80% of U.S. COVID-19 cases went undetected in March 2020.
He and his research team analyzed data from the Centers for Disease Control and Prevention (CDC) on the number of patients who sought medical care for influenza-like illnesses during that time span. That number, said Silverman, was far in excess over what was reported in previous years. By applying probabilistic models that Silverman had developed for the analysis of nonlinear time-series data, they found evidence that this excess influenza-like illness was actually caused by the novel coronavirus — largely going undiagnosed due to limited testing capacity at the start of the pandemic.
Their work was published in the journal Science Translational Medicine, and their findings were covered by CNN, The Economist, WebMD, Business Insider and other major media outlets.
“There were a good two months of my life where I had to put my research aside to answer questions from journalists,” he said.
While the study made a significant impact on the understanding of COVID-19 and yielded great interest from the media and public health officials, Silverman says that he never set out to get involved with researching the novel coronavirus. But his colleague and research scientist at Montana State University,
Alex Washburne — who Silverman describes as “a science cheerleader, someone whose love of science is infectious” — approached him early in the pandemic with a number of observations that could not be explained under the conceptual model of COVID-19 that was common in the field at that time.
“In January [of 2020] he started emailing me about some things he’d noticed in COVID, and about the spread of it around the world that didn’t make sense — particularly how fast it was reported to double in the population,” said Silverman.
They went on to participate in a forecasting challenge from the CDC, through which he and Washburne developed their overarching theory that the disease was moving faster and infecting more people than anyone was reporting.
“We realized that we were seeing just the tip of the iceberg,” said Silverman.
So Washburne, from his office in Montana, and Silverman, who was working in North Carolina at the time, analyzed data of patients seeking treatment for influenza-like illnesses but not diagnosed with the flu to prove their assumptions.
“When Alex and I reconvened a few weeks later, we had gotten almost identical answers from two completely different paths,” said Silverman.
Their work also led Silverman and Washburne to be consulted by various academic, industry and government organizations.
“Presenting our work to Gov. Andrew Cuomo’s task force and being asked how New York state should respond to COVID-19 was a surreal experience,” said Silverman.
With Silverman’s COVID-19 research making a national impact, he feels the obligation to keep moving it forward. He has since written an article outlining the difficulty of determining the true fatality rate of COVID-19, and is currently involved with a wastewater sampling study that aims to give advanced warning of potential COVID-19 outbreaks at Penn State and in the community.
Dual degrees shape research interests
While the ongoing pandemic may not be Silverman’s preferred research focus, his combined medical and statistical training and his research interests in biomedical data make him a well-qualified expert on the topic.
Silverman earned a bachelor’s degree in physics and biophysics from Johns Hopkins University, then he simultaneously pursued both a medical degree and doctorate in computational biology and bioinformatics from Duke University through the Medical Scientist Training Program, funded by the National Institutes of Health. That program graduates approximately 200 candidates annually.
“It’s a combined program,” explained Silverman. “I spent eight years pursuing both degrees, finishing off with med school.”
According to Silverman, he is among the handful of the program’s graduates every year who don’t pursue medical residency after earning their degrees.
“I think it may be six or so students per year that go right into a faculty appointment rather than doing residency or a postdoc,” said Silverman. “And then of those, I can count on one hand the number who have gone into statistics in the past 20 years.”
But, the dual degrees have made both a personal and professional impact on him.
“The M.D. really helps shape my interests,” he said. “Without the M.D., I would probably be in some obscure theoretical branch of math that had very little impact.”
He added, “I have also found that statisticians and clinicians often don’t talk well together, partly because the way that they think is so fundamentally different. Plus, it’s very hard for a biomedical statistician to have a full picture of how the whole health care system works if they haven’t worked in a hospital. I’ve found that it’s been wonderful to really be able to have a foot in both camps.”
Stats at home